A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.

Aart J van der MolenIlona A DekkersIbrahim BediouneElisabeth Darmon-Kern

Published in: European radiology (2022)

• Ioversol has a good safety profile in adult and pediatric patients when IV administered. • ADR and HSR incidence with ioversol, especially those of severe intensity, was among the lowest compared to other ICM. • IV administration of ioversol per se did not increase PC-AKI incidence.

Keyphrases

acute kidney injury
risk factors
end stage renal disease
newly diagnosed
ejection fraction
cardiac surgery
peritoneal dialysis
prognostic factors
early onset
emergency department
drug induced
computed tomography
high intensity
young adults
contrast enhanced
electronic health record